New brain research could reshape our understanding of ADHD and the most common drugs that treat it.

With an expiration date still more than a year away, here's what the latest details reveal.

The FDA has accepted Otsuka’s New Drug Application for centanafadine, a first-in-class norepinephrine, dopamine and serotonin reuptake inhibitor (NDSRI) for the treatment of attention-deficit ...

Concerta and Vyvanse are both long-acting stimulant medications taken to treat ADHD, but they differ in their formulations and additional uses. Both medications effectively improve focus, attention, ...

From 2022 to 2024, stimulant prescriptions issued in Connecticut increased by 13.2 percent, according to data from the state.

The use of medications for Attention-Deficit Hyperactivity Disorder (ADHD) has increased substantially across Europe over the ...

Please provide your email address to receive an email when new articles are posted on . Asian, Black and Hispanic children with ADHD were less likely to be prescribed medication early vs. white ...

UK had highest relative increase of five countries in study, with 20-fold rise in proportion of women over 25 using it ...

This article was reviewed by Lynn Marie Morski, MD, JD. Key Takeaways: ADHD and menopause symptoms can overlap, and one ...